BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 118551)

  • 1. Prevention of experimental subarachnoid hemorrhage-induced intracranial arterial vasonecrosis with phosphodiesterase inhibitor phthalazinol (EG-626).
    Alksne JF; Branson PJ
    Stroke; 1979; 10(6):638-44. PubMed ID: 118551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of vascular ultrastructure in experimental cerebral vasospasm. Myonecrosis of subarachnoid arteries.
    Fein JM; Flor WJ; Cohan SL; Parkhurst J
    J Neurosurg; 1974 Jul; 41(1):49-58. PubMed ID: 4210067
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of persistent cerebral smooth muscle contraction in response to whole blood.
    Linder M; Alksne JF
    Stroke; 1978; 9(5):472-7. PubMed ID: 100906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the effects of intrathecal papaverine in experimental vasospasm.
    Ogata M; Marshall BM; Lougheed WM
    J Neurosurg; 1973 Jan; 38(1):20-5. PubMed ID: 4629882
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiographic study of vasospasm following subarachnoid hemorrhage in monkeys.
    Peerless SJ; Fox AJ; Komatsu K; Hunter IG
    Stroke; 1982; 13(4):473-9. PubMed ID: 7101347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM; Oldfield EH; Boock RJ
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of chronic cerebral vasospasm in dogs with milrinone.
    Khajavi K; Ayzman I; Shearer D; Jones SC; Levy JH; Prayson RA; Skibinski CI; Hahn JF; Chyatte D
    Neurosurgery; 1997 Feb; 40(2):354-62; discussion 362-3. PubMed ID: 9007870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental inhibition of serotonin by antibiotic: prevention of cerebral vasospasm.
    Zervas NT; Hori H; Rosoff CB
    J Neurosurg; 1974 Jul; 41(1):59-62. PubMed ID: 4209213
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructural changes in feline arterial endothelium following subarachnoid hemorrhage.
    Mayberg MR; Houser OW; Sundt TM
    J Neurosurg; 1978 Jan; 48(1):49-57. PubMed ID: 619024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral perivascular nerves in subarachnoid hemorrhage. A histochemical and immunohistochemical study.
    Hara H; Nosko M; Weir B
    J Neurosurg; 1986 Oct; 65(4):531-9. PubMed ID: 3760964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed CSF lavage for arteriographic and morphological vasospasm after experimental SAH.
    Alexander E; Black PM; Liszczak TM; Zervas NT
    J Neurosurg; 1985 Dec; 63(6):949-58. PubMed ID: 4056908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist.
    Zimmermann M; Seifert V; Löffler BM; Stolke D; Stenzel W
    Neurosurgery; 1996 Jan; 38(1):115-20. PubMed ID: 8747959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration by Iloprost of the vasospastic effects of endothelin-1 in rabbit cerebral vessels.
    Keskil IS; Baykaner MK; Sencer H; Ataoğlu O; Ilgit E; Erdoğan B; Ceviker N; Ercan ZS
    Neuroreport; 1994 May; 5(9):1089-92. PubMed ID: 7521681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U74389G prevents vasospasm after subarachnoid hemorrhage in dogs.
    Macdonald RL; Bassiouny M; Johns L; Sajdak M; Marton LS; Weir BK; Hall ED; Andrus PK
    Neurosurgery; 1998 Jun; 42(6):1339-45; discussion 1345-6. PubMed ID: 9632194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine on the development of cerebral vasospasm in a primate model.
    Handa Y; Hayashi M; Takeuchi H; Kobayashi H; Kawano H; Kabuto M
    Neurosurgery; 1991 Mar; 28(3):380-5; discussion 385-6. PubMed ID: 2011219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrugation of cerebral vessels following subarachnoid hemorrhage: comparison of two experimental models of chronic cerebral vasospasm.
    Rickels E; Seifert V; Zumkeller M; Kunz U; Reale E
    Exp Neurol; 1990 Feb; 107(2):178-86. PubMed ID: 2303126
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone.
    Nishiguchi M; Ono S; Iseda K; Manabe H; Hishikawa T; Date I
    Neurosurgery; 2010 Jan; 66(1):158-64; discussion 164. PubMed ID: 20023546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of computed tomography in the prediction of cerebral vasospasm after aneurysm rupture.
    Mizukami M; Takemae T; Tazawa T; Kawase T; Matsuzaki T
    Neurosurgery; 1980 Dec; 7(6):583-6. PubMed ID: 7207754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.